This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (43)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Evaggelos Neonakis, MD; Malcolm H. Wheeler, MD; Hari Krishnan, MD; Gerry A. Coles, MD; Felicity Davies, MB; J. Stuart Woodhead, MD

Arch Surg. 1995;130(6):643-648.

Abstract
Objective
To assess the outcome of parathyroidectomy for renal failure—related hyperparathyroidism.

Design
A retrospective analysis with a mean follow-up of 4.34 years of a case series of 67 consecutive patients with renal failure—associated hyperparathyroidism.

Setting
All patients were operated on at the University Hospital of Wales and Cardiff Royal Infirmary between October 1981 and December 1991.

Patients
Of the 67 consecutive patients, 35 were receiving hemodialysis and 32 had received a renal transplant.

Intervention
Total parathyroidectomy with autotransplantation was performed in 52 patients and subtotal parathyroidectomy was performed in 15.

Main Outcome Measures
Symptomatic improvement after parathyroidectomy, the normalization of biochemical parameters, and the rate of recurrent hyperparathyroidism after parathyroidectomy.

Results
Symptomatic improvement after parathyroidectomy occurred in 81% of hemodialysis patients and in 72% of transplant patients. The best predictor for successful relief of skeletal pain after parathyroidectomy was an elevated preoperative alkaline phosphatase level. Recurrent hyperparathyroidism developed in four of 38 patients after total parathyroidectomy with autotransplantation and in one of 14 surviving patients after subtotal parathyroidectomy. All five patients with recurrent disease were hemodialysis patients (22%).

Conclusions
Transplant patients usually present with less severe disease, have better normalization of biochemical parameters after parathyroidectomy, and rarely develop recurrent hyperparathyroidism compared with hemodialysis patients. Both total parathyroidectomy with autotransplantation and subtotal parathyroidectomy result in good control of renal hyperparathyroidism with excellent improvement of symptoms.

(Arch Surg. 1995;130:643-648)

Author Affiliations
From the Departments of Surgery (Drs Neonakis, Wheeler, and Krishnan) and Medicine (Dr Coles and Ms Davies), Cardiff (Wales) Royal Infirmary, and the Department of Biochemistry, University Hospital of Wales, Cardiff (Dr Woodhead).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients
Mazzaferro et al.
Nephrol Dial Transplant 2008;23:2319-2323.
ABSTRACT | FULL TEXT  

Decreased renal transplant function after parathyroidectomy
Schwarz et al.
Nephrol Dial Transplant 2007;22:584-591.
ABSTRACT | FULL TEXT  

Parathyroid disease and calcium metabolism
Mihai and Farndon
Br J Anaesth 2000;85:29-43.
FULL TEXT  

Long-term Results of Subcutaneous Parathyroid Grafts in Uremic Patients
Kinnaert et al.
Arch Surg 2000;135:186-190.
ABSTRACT | FULL TEXT  

Prospective Evaluation of Total Parathyroidectomy and Autotransplantation for the Treatment of Secondary Hyperparathyroidism
Zaraca et al.
Arch Surg 1999;134:68-72.
ABSTRACT | FULL TEXT